1 Hr
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
1 Hrالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
1 HrReady to play
Ready to play
A new study has found that weight loss drugs containing the compound "semaglutide" from the "GLP-1" class, such as "Ozempic" and "Wegovy," may help extend the lifespan of mice by more than 12%, while also improving blood sugar regulation, appearance, and behavior. The study lasted over three months, and the results showed more significant health and longevity benefits compared to a low-calorie diet, with evidence suggesting that these drugs might act through a biological pathway independent of calorie reduction. The findings indicate the potential for humans to benefit from these medications in reducing age-related diseases and achieving broad health advantages, though further research is necessary to confirm this.
Notice: This Is an AI-Generated Summary
Comments (0)